These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 9494706
1. Reproducibility of plasma catecholamine metabolites in normal subjects. Amin F, Hashmi A, Stroe AE, Adebogun O, Densmore D, Knott PJ. Biol Psychiatry; 1998 Feb 01; 43(3):233-5. PubMed ID: 9494706 [Abstract] [Full Text] [Related]
2. Unconjugated methoxylated catecholamine metabolites in human saliva. Quantitation methodology and comparison with plasma levels. Drebing CJ, Freedman R, Waldo M, Gerhardt GA. Biomed Chromatogr; 1989 Sep 01; 3(5):217-20. PubMed ID: 2804429 [Abstract] [Full Text] [Related]
3. Plasma levels of metabolites of catecholamine in nicotine-dependent patients treated with varenicline. Umene-Nakano W, Yoshimura R, Yoshii C, Hayashi K, Ikenouchi-Sugita A, Katsuki A, Hori H, Nakamura J. Nicotine Tob Res; 2012 Apr 01; 14(4):486-9. PubMed ID: 22006914 [Abstract] [Full Text] [Related]
4. [Significance of umbilical plasma concentrations of catecholamines and their metabolites in patients with term vaginal deliveries]. Ishizuka B, Hirata K, Matsumoto K, Ohno Y, Watanabe K, Kondoh T, Horikoshi H, Shiozaki K, Hamada H. Nihon Sanka Fujinka Gakkai Zasshi; 1991 Jul 01; 43(7):729-34. PubMed ID: 1890351 [Abstract] [Full Text] [Related]
5. Stress at work alters serum brain-derived neurotrophic factor (BDNF) levels and plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) levels in healthy volunteers: BDNF and MHPG as possible biological markers of mental stress? Mitoma M, Yoshimura R, Sugita A, Umene W, Hori H, Nakano H, Ueda N, Nakamura J. Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr 01; 32(3):679-85. PubMed ID: 18160197 [Abstract] [Full Text] [Related]
6. Plasma catecholamine metabolites and early response to haloperidol. Bowers MB, Swigar ME, Jatlow PI, Goicoechea N. J Clin Psychiatry; 1984 Jun 01; 45(6):248-51. PubMed ID: 6725216 [Abstract] [Full Text] [Related]
7. Plasma catecholamine metabolites as markers for psychosis and antipsychotic response in schizophrenia. Kelley ME, Yao JK, van Kammen DP. Neuropsychopharmacology; 1999 Jun 01; 20(6):603-11. PubMed ID: 10327429 [Abstract] [Full Text] [Related]
8. Genetics of monoamine metabolites in baboons: overlapping sets of genes influence levels of 5-hydroxyindolacetic acid, 3-hydroxy-4-methoxyphenylglycol, and homovanillic acid. Rogers J, Martin LJ, Comuzzie AG, Mann JJ, Manuck SB, Leland M, Kaplan JR. Biol Psychiatry; 2004 Apr 01; 55(7):739-44. PubMed ID: 15039003 [Abstract] [Full Text] [Related]
9. Plasma homovanillic acid and the dopamine transporter during cocaine withdrawal. Bowers MB, Malison RT, Seibyl JP, Kosten TR. Biol Psychiatry; 1998 Feb 15; 43(4):278-81. PubMed ID: 9513737 [Abstract] [Full Text] [Related]
10. Plasma monoaminergic metabolites and catecholamines in subarachnoid hemorrhage. Clinical implications. Minegishi A, Ishizaki T, Yoshida Y, Ahagon A, Shibata N, Kobayashi H. Arch Neurol; 1987 Apr 15; 44(4):423-8. PubMed ID: 2435272 [Abstract] [Full Text] [Related]
11. Effects of handling or immobilization on plasma levels of 3,4-dihydroxyphenylalanine, catecholamines, and metabolites in rats. Kvetnanský R, Goldstein DS, Weise VK, Holmes C, Szemeredi K, Bagdy G, Kopin IJ. J Neurochem; 1992 Jun 15; 58(6):2296-302. PubMed ID: 1573408 [Abstract] [Full Text] [Related]
12. Dexamethasone increases plasma HVA but not MHPG in normal humans. Wolkowitz OM, Sutton ME, Doran AR, Labarca R, Roy A, Thomas JW, Pickar D, Paul SM. Psychiatry Res; 1985 Oct 15; 16(2):101-9. PubMed ID: 3865250 [Abstract] [Full Text] [Related]
13. Normal-range plasma catecholamines in patients with generalized and acrofacial vitiligo: preliminary report. Orecchia G, Frattini P, Cucchi ML, Santagostino G. Dermatology; 1994 Oct 15; 189(4):350-3. PubMed ID: 7873818 [Abstract] [Full Text] [Related]
14. Plasma levels of brain derived-neurotrophic factor and catecholamine metabolites are increased during active phase of psychotic symptoms in CNS lupus: a case report. Ikenouchi A, Yoshimura R, Ikemura N, Utsunomiya K, Mitoma M, Nakamura J. Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep 30; 30(7):1359-63. PubMed ID: 16626841 [Abstract] [Full Text] [Related]
15. Effect of risperidone on plasma catecholamine metabolites and brain-derived neurotrophic factor in patients with bipolar disorders. Yoshimura R, Nakano Y, Hori H, Ikenouchi A, Ueda N, Nakamura J. Hum Psychopharmacol; 2006 Oct 30; 21(7):433-8. PubMed ID: 17029305 [Abstract] [Full Text] [Related]
16. Central nervous system catecholamine metabolism in Korsakoff's psychosis. Martin PR, Weingartner H, Gordon EK, Burns RS, Linnoila M, Kopin IJ, Ebert MH. Ann Neurol; 1984 Feb 30; 15(2):184-7. PubMed ID: 6200058 [Abstract] [Full Text] [Related]
17. Assessment of brain dopamine metabolism from plasma HVA and MHPG during debrisoquin treatment: validation in monkeys treated with MPTP. Kopin IJ, Bankiewicz KS, Harvey-White J. Neuropsychopharmacology; 1988 May 30; 1(2):119-25. PubMed ID: 3266957 [Abstract] [Full Text] [Related]
18. Relationship between 3-methoxy-4-hydroxyphenylglycol and homovanillic acid in saliva and plasma of healthy volunteers. Yang RK, Yehuda R, Holland DD, Knott PJ. Biol Psychiatry; 1997 Nov 01; 42(9):821-6. PubMed ID: 9347131 [Abstract] [Full Text] [Related]
19. Relationship between plasma and cerebrospinal fluid norepinephrine and dopamine metabolites in a nonhuman primate. Greene KA, Faull KF. J Neurochem; 1989 Oct 01; 53(4):1007-13. PubMed ID: 2769251 [Abstract] [Full Text] [Related]
20. Plasma catecholamines and their metabolites in obsessive-compulsive disorder. Benkelfat C, Mefford IN, Masters CF, Nordahl TE, King AC, Cohen RM, Murphy DL. Psychiatry Res; 1991 Jun 01; 37(3):321-31. PubMed ID: 1891512 [Abstract] [Full Text] [Related] Page: [Next] [New Search]